In France, for several years now, successive anti-gift laws have continued to raise many difficulties in their application.
On the one hand, the publication on 15 June 2020 of the decree relating to the supervision of benefits (LEA) brings new constraints in the declaration of transactions for the benefit of healthcare professionals (PDS). On the other hand, the application of the law of 29 December 2011 and the decree of 21 May 2013 maintains the requirement to publish conflicts of interest between healthcare professionals and the pharmaceutical industry.
It is essential to structure yourself and find solutions to meet these regulatory requirements and constraints. How can you ensure that the data you report and publish is complete and accurate?